ABSTRACT Centriole-to-centrosome conversion (CCC) safeguards centriole homeostasis by coupling centriole duplication with segregation, and is essential for stabilization of mature vertebrate centrioles naturally devoid of the geometric scaffold or the cartwheel. Here we identified PPP1R35, a putative regulator of the protein phosphatase PP1, as a novel centriolar protein required for CCC. We found that PPP1R35 is enriched at newborn daughter centrioles in S or G2 phase. In the absence of PPP1R35, centriole assembly initiates normally in S phase, but none of the nascent centrioles can form active centrosomes or recruit CEP295, an essential factor for CCC. Instead, all PPP1R35-null centrioles, although stable during their birth in interphase, become disintegrated after mitosis upon cartwheel removal. Surprisingly, we found that neither the centriolar localization nor the function of PPP1R35 in CCC requires the putative PP1-interacting motif. PPP1R35 is thus acting upstream of CEP295 to induce CCC for proper centriole maintenance.
INTRODUCTION
Centriole homeostasis in animal cycling cells is carefully maintained. In vertebrates, cells begin the cell cycle with two centrioles, each of which is capable of initiating duplication in S phase, generating two mother-daughter centriole pairs. Duplication starts from the formation of the cartwheel upon which other components are assembled. In mitosis, the two pairs of centrioles segregate equally to two daughter cells through association with the spindle poles, restoring the normal copy number of centrioles for the next cell cycle. Centrioles can duplicate and associate with spindle poles only when they have been converted to centrosomes (Wang et al., 2011) . The conversion is a process in which newborn centrioles acquire the competence to recruit the pericentriolar material (PCM) and thereby function as the microtubule-organizing center (MTOC) or centrosome (Wang et al., 2011) . It starts in early mitosis depending on Plk1 activity, and completes at the end of the cell cycle, giving rise to one old/previously converted and one newly converted centriole that are both MTOC-competent to start the new cell cycle. Only the converted, MTOC-competent centriole can duplicate and then carries the newborn, MTOC-noncompetent daughter centriole to which it is engaged through the segregation process, ensuring centriole homeostasis. Interestingly, concurrent with centriole-to-centrosome conversion (CCC), the cartwheel is removed from newborn centrioles during mitosis, depending also on Plk1. The functional relationship between centrosome formation and cartwheel removal had been largely unknown until the identification of CEP295 as the centriolar factor specifically required for the CCC (Izquierdo et al., 2014; Tsuchiya et al., 2016) , but not for cartwheel removal, uncoupling these two events (Izquierdo et al., 2014) . In addition, it was reported that CEP295 is required for proper elongation of centrioles (Chang et al., 2016) . In Drosophila, both the Polo kinase and the functional homologue of CEP295, Ana1, have been shown to mediate a similar process of CCC (Fu et al., 2016; Novak et al., 2016; Saurya et al., 2016) . However, unlike vertebrates, fly centrioles do not lose their cartwheel during the cell cycle.
Human CEP295 is enriched at newborn centrioles in the beginning of centriole duplication in S phase (Izquierdo et al., 2014) . Depletion of CEP295 has no effect on old (or mother) centrioles already converted to centrosomes, but it completely abolishes the ability of newborn centrioles to recruit the PCM (e.g., γ-tubulin). In contrast, cartwheel removal from newborn centrioles can still occur normally in the absence of CEP295. Thus, upon acute knockdown of CEP295, cells exiting from mitosis were found to inherit two "cartwheel-less" centrioles: one (the mother) with the PCM and one (the newborn/daughter) without, instead of two cartwheel-less, PCM-associating centrioles normally seen in wild-type G1 cells. These unusual centrioles, devoid of both the cartwheel and PCM, are unstable, becoming disintegrated gradually after mitosis. It has therefore led to the proposal that loss of the cartwheel can be detrimental to centrioles, and that CCC mediated by CEP295 must occur in parallel to stabilize "cartwheel-less" centrioles for duplication. Consistently, in the current study, we identify another centriolar factor named PPP1R35, which acts upstream of CEP295 to promote centriole-to-centrosome conversion, mediating a process fundamentally essential for the stability and homeostasis of centrioles or centrosomes in vertebrate cycling cells.
RESULTS AND DISCUSSION
PPP1R35 is recruited to and enriched at newborn daughter centrioles during S/G2 phase Using the quantitative proteomics SILAC (stable isotope labeling by amino acid in cell culture) screen established previously (Tanos et al., 2013; Wang et al., 2013) , we have identified centriolar proteins enriched at newborn daughter centrioles in S phase ( Figure 1A ). Among them, PPP1R35/C7ORF47, a protein annotated as a putative regulator of the protein phosphatase PP1 (Hendrickx et al., 2009; Fardilha et al., 2011) , has not been functionally associated with the centrosome, although it is in the published centrosome proteome (Jakobsen et al., 2011) . Using a rabbit polyclonal antibody we generated, which recognizes the N-terminal half of FIGURE 1: PPP1R35 is enriched on daughter centrioles. (A) Schematic outlining the SILAC screen used to classify centrosomal proteins (Tanos et al., 2013; Wang et al., 2013) . Two populations of differentially labeled centrosomes were purified in equal amounts. One population of centrosomes (labeled with light isotopes) was isolated from cells arrested in S phase, while the other (labeled with heavy isotopes) was from cells arrested in S phase and overexpressing Plk4. The former consisted mainly of one mother and one daughter centriole pair, while the latter was made up of one mother and four to six daughter centrioles complex, or what is commonly known as the centriole rosette. The mixture was subject to a quantitative proteomics analysis SILAC, and proteins that exhibited a high heavy:light (H/L) isotope ratio were considered as daughter centriole protein candidates. A list of candidates identified by the high H/L ratios is shown. Highlighted in red is PPP1R35, which has a H/L ratio similar to that of the daughter centriole protein SAS-6. (B) PPP1R35 localizes to all centrioles throughout the cell cycle, but is more enriched at newborn daughter centrioles in S/G2 phase. Immunofluorescence (IF) images of RPE1 cells at different stages of the cell cycle showing centrin2-GFP (green), PPP1R35 (red), SAS-6 (blue; pseudocolored), and DAPI (blue). Mother (M) and daughter (D) centrioles were marked. Scale bar = 5 μm; 1 μm in inset. (C) Colocalization of PPP1R35 (red) with SAS-6 (blue) at the centriole rosette in PLK4 overexpressing cells. Centrin2-GFP marks centrioles. Scale bar = 5 μm; 1 μm in inset.
PPP1R35, we found PPP1R35 localizes to all centrioles throughout the cell cycle of diploid, nontransformed retinal pigment epithelial (RPE) cells ( Figure 1B) . Interestingly, PPP1R35 exhibited preferential localization to newborn daughter centrioles during S, G2, and M phases ( Figure 1B) , a localization pattern similar to that of CEP295 (Izquierdo et al., 2014) . The same localization pattern was also observed in multiple human cell lines that we examined (U2OS, HeLa, and 16HBE; unpublished data). Consistently, when we overexpressed PLK4 to induce the formation of centriole rosettes, PPP1R35 localizes to all the daughter centrioles encircling the mother centrioles, in a localization pattern similar to that of daughter centriole protein SAS-6 known to mark the cartwheel ( Figure 1C ). The PPP1R35 antibody we generated is specific as the centriolar signals identified diminished upon depletion of PPP1R35 by RNA interference (RNAi) (Figure 2A ). Taken together, our findings establish that PPP1R35 is a daughter-enriched centriolar protein.
Loss of PPP1R35 leads to centrosome reduction and centriole disintegration
We found that knockdown of PPP1R35 in asynchronous cycling cells using small interfering RNA (siRNA) resulted in a reduction of centriole number in the majority of cells examined at S phase ( Figure 2 , A and B), suggesting that PPP1R35 is required for centrosome biogenesis. To confirm and study the impact of PPP1R35 on centrosome biogenesis in detail, we generated a stable RPE1 PPP1R35 −/− cell line using CRISPR/Cas9-mediated gene targeting. Because centrosome loss activates a p53-dependent G1 arrest in human cells, the PPP1R35 −/− cell line was generated in a p53 −/− background. We found that PPP1R35
−/− cells proliferate in the absence of centrosomes ( Figure 2C ), as no γ-tub foci were detected in the cells ( Figure 2D ). The centrosome loss defect in PPP1R35
−/− cells could be rescued by reintroduction of wild-type PPP1R35 into the cells, thus confirming the specificity of the phenotype ( Figure 2E ).
Despite not having any centrosomes, we could detect multiple centrin foci in ∼30% of PPP1R35 −/−
; p53
−/− cells grown asynchronously ( Figure 2F ). These centrin foci were found to colocalize with the cartwheel component SAS-6 and other centriolar markers ( Figure 2F ) but not with the PCM-associated markers ( Figure 2G ), suggesting that they are not random aggregates but nascent centrioles formed in the absence of PPP1R35. The presence of centriole singlets constantly in a fraction of steady-state, asynchronously growing PPP1R35
−/− cells suggests that centrioles are continuously being synthesized de novo and disintegrated during the cell cycle, a phenotype highly similar to that seen in CEP295 knockout cells (Izquierdo et al., 2014) . To test this, we synchronized PPP1R35
−/− cells in S, G2, M, and G1 phase and monitored the presence of centrioles. We found that de novo centrioles carrying the cartwheel can be detected in the majority of cells arrested in S and G2 phase (Figure 2, F and H), whereas most of the M-or G1-arrested cells do not carry centrioles ( Figure 2H ). Note that in the unsynchronized PPP1R35 −/−
−/− population, more than 60% of normal (nonarrested) mitotic cells do carry de novo-formed centrioles, indicating that centriole disintegration starts in M phase and completes after mitotic exit ( Figure 2H ), the same period of time during which cartwheel removal occurs. To test if centriole disintegration in PPP1R35
−/− cells depends on cartwheel removal, cells were allowed to go through mitosis in the absence of Plk1 activity ( Figure 2I ), a treatment known to block cartwheel removal (Tsou et al., 2009; Izquierdo et al., 2014) . Indeed, we found that PPP1R35-null centrioles inhibited of cartwheel removal by Plk1 inactivation can stably exist in G1-arrest cells ( Figure 2I ), a property similar to that of CEP295-null centrioles. Together, our data demonstrate that centrioles are formed de novo in PPP1R35
−/− cells during each S phase, and these centrioles become disintegrated after cartwheel removal in late mitosis and G1. PPP1R35 is hence not required for the initial assembly of centrioles, but it is essential for the stabilization of centrioles losing the cartwheel at the end of mitosis.
PPP1R35 is required for CEP295 recruitment and essential for the conversion of newborn centrioles to centrosomes 
−/− cells also displayed colocalization with multiple centriole markers including CEP120, CEP135, CP110, Centrobin, STIL, and SAS-6 ( Figure  3B ). However, the daughter-enriched centriole protein CEP295 was absent from the centrioles formed in PPP1R35
−/− cells ( Figure  3 , B and C). Intriguingly, although PPP1R35 is required for CEP295 localization, we found that PPP1R35 can localize to CEP295-null centrioles normally (Figure 3 , B and D), indicating that PPP1R35 acts upstream of CEP295.
CEP295 has been shown to be required for the stabilization of newborn centrioles as they exit mitosis. The stabilization is conferred through the acquisition of PCM by the newborn centrioles in a process known as CCC. Once the newborn centriole has been converted to centrosomes, however, CEP295 is no longer needed for the maintenance of the centrosome activity. As PPP1R35 is required for CEP295 localization (Figure 3 , B and C), it should have a similar impact on newborn but not mother centrioles. To test this, we used siRNA to knock down PPP1R35, and monitored the short-term effect on both mother and newborn centrioles exiting from mitosis for colocalization with centrosome markers γ-tubulin and C-Nap1. When control mitotic cells, each of which carries four centrioles (two mothers and two newborn daughters), were forced to exit mitosis and enter the G1 phase without undergoing cytokinesis, four centrin foci colocalizing with γ-tubulin and C-Nap1 were detected, indicating that all newborn centrioles underwent CCC ( Figure 3E ). In contrast, in the absence of PPP1R35, cells exited mitosis with only two out of the four centrin foci carrying the centrosome markers ( Figure 3E ). These results indicate that PPP1R35 is indeed essential for the conversion of newborn centrioles into centrosomes, consistent with the long-term effect of PPP1R35 depletion seen in our PPP1R35 knockout cells, which completely lack active centrosomes (Figure 2 ).
Neither the consensus PP1-interacting motif nor the known Plk1 phosphorylation site of PPP1R35 is essential for CCC PPP1R35 carries a putative PP1-interacting site (RQVRF; amino acids 77-81) that is conserved in vertebrates, and has been reported to physically associate with the protein phosphatase 1 (PP1) in a large screen for PP1 interactors (Hendrickx et al., 2009; Fardilha et al., 2011) . To investigate whether the putative PP1-interacting site of PPP1R35 is required for CCC, we deleted the entire site and examine if the mutant protein (PPP1R35 
−/− cells were allowed to enter mitosis in the presence of the Plk1 inhibitor (BI-2536), or Eg5 inhibitor (monastrol) as a control, and release to and arrest at G1 by Cdk inhibition with roscovitine for 16 h before fixation for examining de novo centrioles. Cells going through this type of manipulation are known to display donut-shaped, multilobed, or multiple small nuclei as described before (Tsou et al., 2009) , and were thereby identified for analyses. In Plk1-inhibited cells arrested in G1, de novo centrioles that retained the cartwheel (SAS-6), centrin and CP110 were stably present. Quantifications are shown. Data are means ± SD. n > 100, N = 3.
between PPP1R35
ΔRQVRF and PP1 by coimmunoprecipitation experiment ( Figure 4B ). We then mutated another loosely conserved potential PP1-interacting site (SKRLF; amino acids 157-161; PPP1R35 F161A ), alone or together with the RQVRF site, but again found that the mutant proteins disrupted neither the function of PPP1R35 in centrosome biogenesis nor its interaction with PP1 (Supplemental Figure S1 , A and B). Our data thus suggest that either the interaction of PPP1R35 with PP1 can be nonspecifically created in our and the previous assays (Hendrickx et al., 2009; Fardilha et al., 2011) , or there are noncanonical PP1-interacting motifs yet to be identified in PPP1R35.
Plk1 is the kinase required for CCC (Wang et al., 2011; Novak et al., 2016) . Intriguingly, in a published proteomics screen (Oppermann et al., 2012) , PPP1R35 has been identified as a high confident Plk1 substrate during mitosis, with three phosphorylation sites (serine 45, 47, and 52) being mapped in the N-terminal region of the protein ( Figure 4C ). Indeed, in our gel mobility shift assay, PPP1R35 was found hyperphosphorylated during mitosis, largely depending on these three serine sites (Figure 4, C and D) . We thus asked whether PPP1R35 phosphorylation is crucial for its CCC function. We found that expression of either the phosphor-null (PPP1R35 
; p53
−/− cells ( Figure 4E ). In contrast, the N-terminal half of PPP1R35 (1-102 amino acids; PPP1R35 NT ) was unable to promote or rescue centrosome formation in the knockout cells ( Figure 4E) . Our data hence demonstrate that the activity of PPP1R35 in driving centrosome biogenesis can be sufficiently supported by the C-terminal half of the protein, independent of the known Plk1 phosphorylation sites and PP1-interacting motif both located in the N-terminus.
We have identified PPP1R35 as a novel daughter centriole enriched protein acting upstream of CEP295 to drive CCC. A recent study showed that PPP1R35 is also involved in centriole elongation Sydor et al., 2018) , similar to CEP295 (Chang et al., 2016) . Two previous studies independently identified PPP1R35 as one of more than 70 PP1 phosphatase regulators in human cells (Hendrickx et al., 2009; Fardilha et al., 2011) . The interaction of PPP1R35 with PP1 was shown separately by the pull-down assay using bacteria-purified proteins, yeast two-hybrid assay, and coimmunoprecipitation assay (this study). Most of the known PP1 interactors contain the PP1-interacting site, with a consensus sequence as [HKR]-
. PPP1R35 can be found in deuterostome animals, but its putative PP1-interacting site (RQVRF) is highly conserved only in vertebrates (100% identical between zebrafish and human). Although our data indicate that the PP1-interacting site of PPP1R35 is not essential for centrosome formation or PP1 association, we anticipate a possibility that it may have an undefined regulatory role associating with other activities of the vertebrate centrosome, perhaps including, for example, the control of 
−/− cells stably expressing various indicated PPP1R35 mutants were examined for the presence of centrosomes. PPP1R35
NT encodes the first 102 amino acid residues while PPP1R35 CT encodes the 103-253 residues. Numbers in the merged image indicate the percentage of cells with centrosomes. Scale bar = 5 μm.
ciliogenesis specific for vertebrate cells. More studies are required to test these ideas.
MATERIALS AND METHODS

Cell culture
RPE1 cells were cultured in DME/F-12 (1:1) medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. The RPE1 tetracycline-inducible PLK4as cells (PLK4 −/− ; tet-PLK4as) were grown under a constant supply of 5 ng/ml doxycycline replaced every 2 d to support centrosome biogenesis. To inhibit PLK4 as , 2 μM of 3MBPP1 was added to the media. To reactivate PLK4 as , cells were washed five times with fresh media to remove 3MBPP1. BrdU was added to culture medium at 30 μM for 30 min before fixation to label S-phase cells. Aphidicolin (2 μg/ml) was used to arrest cells in S phase. Cdk1 inhibitor RO-3306 (10 μM) was used to arrest cells at G2/M boundary. For M phase arrest, cells were treated with 200 ng/ ml nocodazole. To arrest cells in G1, cells were washed three times with serum-free media and grown in serum-free media for 2 d. ; tetPLK4as) was generated in our lab (Kim et al., 2016 , and PPP1R35 doublePP1 (R76,R77,F81,F161A) constructs were created with site-directed mutagenesis (Stratagene), and were used for subcloning into pcDNA3-FLAG-HA and pLVX-Tight-Puro vector. PPP1CA was amplified from a cDNA library from HeLa cells made in our lab, and was cloned into pcDNA3-FLAG-HA vector.
Cell lines and plasmid constructs
CRISPR-mediated gene targeting
RNA-guided targeting of PPP1R35 in human cells was achieved through coexpression of the Cas9 protein with guide RNAs (gRNAs) using reagents as described previously (Mali et al., 2013) , which are available from Addgene (www.addgene.org/crispr/church/). Three gRNAs were used together to knock out PPP1R35 in RPE1 cells. Sequences of PPP1R35 gRNAs used are as follows: (5′-GAGTCAGAGCTGA AGT CGG-3′), (5′-GCGGAC-GGGGAAGAAGCCG-3′), and (5′-GCCTTG GGCCTGGAGCTGC-3′). All gRNAs were cloned into the gRNA cloning vector (Addgene plasmid #41824) via the Gibson assembly method (New England Biolabs) as described previously (Mali et al., 2013) . Cas9 plasmid (5 μg; Addgene plasmid #41815) and gRNA (5 μg) were nucleofected according to manufacturer's instructions (Lonza). Cells were examined for the loss of proteins and centrosomes 7 d after nucleofection.
